|
> Home
> The Company
> The Product
> Patents - Licences
> News
|
|
Patent situation
Europe:
- Broad and professional patent protection
- Protected in the United Kingdom, in France, Germany, Italy and Portugal
North America:
- Broad and professional patent protection
- Protected in the USA and Canada
Worldwide patents are in place for DCP. The above mentioned country list
is not complete.
At present we do have various and reliable contacts with very well known
pharmaceutical companies. Some of them have informed us, that if we have
multi centre phase 1 clinical trial results conducted under FDA and EMEA
standards and showing low toxicity and a clear therapeutic effect, that
they would be interested to in-license this compound. After a successful
conclusion of the clinical trial phase 1 and considering the competition
factor amongst the interested parties, Bioplatin Ltd, together with its
advisers, will be in an excellent position to take advantage of this competitive
environment.
|
|